Diabetic Foot Ulcer Treatment Market Outlook:
Diabetic Foot Ulcer Treatment Market size was valued at USD 6.92 billion in 2025 and is likely to cross USD 12.51 billion by 2035, expanding at more than 6.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of diabetic foot ulcer treatment is assessed at USD 7.3 billion.
Key Diabetic Foot Ulcer Treatment Market Insights Summary:
Regional Highlights:
- North America diabetic foot ulcer treatment market will hold over 38.8% share by 2035, driven by rising peripheral neuropathy cases among diabetics and increasing treatment options for ulcer diagnosis.
- Asia Pacific market will achieve substantial growth during the forecast timeline, driven by the rising diabetes patient population and lack of timely diagnosis in the region.
Segment Insights:
- The neuropathic ulcer segment in the diabetic foot ulcer treatment market is anticipated to hold the largest share by 2035, attributed to the rising prevalence of peripheral neuropathy and associated ulcer risks.
- The hospitals segment in the diabetic foot ulcer treatment market is expected to achieve a significant share by 2035, driven by the need for intensive care to prevent complications like amputations.
Key Growth Trends:
- An Increase In Sedentary Lifestyles
- Rise in The Geriatric Population Around The World
Major Challenges:
- An Increase In Sedentary Lifestyles
- Rise in The Geriatric Population Around The World
Key Players: UPM, Orpyx Medical Technologies Inc., PENTAX Medical, Smith & Nephew plc, Organogenesis Inc., SIGVARIS GROUP, 3M, Molnlycke Health Care AB, Hill-Rom Holdings, Inc., ConvaTec Inc.
Global Diabetic Foot Ulcer Treatment Market Forecast and Regional Outlook:
Market Size & Growth Projections:
- 2025 Market Size: USD 6.92 billion
- 2026 Market Size: USD 7.3 billion
- Projected Market Size: USD 12.51 billion by 2035
- Growth Forecasts: 6.1% CAGR (2026-2035)
Key Regional Dynamics:
- Largest Region: North America (38.8% Share by 2035)
- Fastest Growing Region: Asia Pacific
- Dominating Countries: United States, Germany, Japan, United Kingdom, China
- Emerging Countries: China, India, Japan, South Korea, Malaysia
Last updated on : 8 May, 2025
The growth of the market can be attributed to the increasing number of people suffering from diabetes worldwide. The World Health Organization reports that in 2019, diabetes directly caused 1.5 million deaths, with 48% of deaths caused by diabetes occurring before 70 years of age. According to the American Diabetes Association, approximately 11.3% of the American population, or 37.3 million people, had diabetes in 2019. There are 37.3 million adults with diabetes, 28.7 million of whom are diagnosed, and 8.5 million of whom are undiagnosed.
An ulcer on the bottom of the foot is one of the most common diabetic foot complications. By reducing the pressure, promoting healing, and minimizing the chances of amputation, diabetic foot ulcer treatments are particularly useful for treating diabetic foot ulcers. With the aid of advanced medical technology, the diabetic foot ulcer treatment market strives to provide the best possible services in order to facilitate faster and better wound healing for diabetics. Globally, diabetes is becoming one of the most prevalent diseases. Moreover, the rapid adoption of novel wound care devices, the increase in chronic illnesses, such as diabetes and cancer, have contributed to an increase in diabetic foot ulcers among diabetics, and increased disposable incomes are projected to drive market growth over the forecast period. In July 2022, the Bureau of Economic Analysis reported an increase of USD 37.6 billion in disposable personal income, while personal income was up 0.2%.
Diabetic Foot Ulcer Treatment Market Growth Drivers and Challenges:
Growth Drivers
-
An Increase In Sedentary Lifestyles- According to the Centers For Disease Control And Prevention, approximately 60% of U.S. adults fail to engage in an adequate amount of physical activity. Nearly 25 percent of American adults are completely sedentary. An increasing number of diabetics are being diagnosed as a result of physical inactivity. In times of rapid modernization, the food habits of the people have been adversely affected, which in turn has been combined with a faulty and inactive lifestyle. Ultimately, this results in the onset of diabetes and leads to the formation of diabetic foot ulcers as a result. This factor is anticipated to drive global diabetic foot ulcer treatment market growth over the forecast period.
-
Rise in The Geriatric Population Around The World- The group of elderly are particularly affected by diabetes, as their immunity lowers due to old age, they become the prime age group to be burdened with diabetic foot ulcers. According to a recent report published by the World Bank, at the end of 2021, there were a total of 747,238,580 people over 60 years of age living around the world, and the number of elderly people is anticipated to rise in the future.
-
Rapidly Growing Number of People Developing Diabetic Foot Ulcers (DFU)- It is estimated that between 9 and 26 million people worldwide suffer from diabetic foot ulcers every year. A diabetic foot ulcer is likely to develop during the lifetime of 16 to 24% of patients with diabetes complications.
-
Increasing Prevalence of Obesity Worldwide- Obesity is one the primary risk factors of diabetic ulcers, obesity defects the tissues that causes insulin resistance and glucose uptake. In the period 2000-2020, obesity prevalence increased by 30.5% to 41.9% in the United States. Ages 20-39 showed an obesity prevalence of 39.8%, 40-59 age groups, 44.3%, and 60+ age groups showed a prevalence of 41.5%.
-
Surge In Number Of People Suffering From Type 2 Diabetes - It is expected that the worldwide prevalence of type 2 diabetes will increase to 70,000 per 100,000 individuals by 2030, reflecting an increase in prevalence across all regions of the world.
Challenges
- High Cost Associated With Advanced Diabetic Foot Ulcer Treatment-despite of the high prevalence of diabetic patients and diabetic foot ulcers, there are no adequate reimbursement policies for its treatment. Moreover, the devices used for advanced wound care are also expensive, which makes the allover treatment costly.
- Patient Management Rules and Regulations
- Unawareness of the Availability of Treatment For Diabetic Foot Ulcers
Diabetic Foot Ulcer Treatment Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
6.1% |
|
Base Year Market Size (2025) |
USD 6.92 billion |
|
Forecast Year Market Size (2035) |
USD 12.51 billion |
|
Regional Scope |
|
Diabetic Foot Ulcer Treatment Market Segmentation:
Ulcer Type
The global diabetic foot ulcer treatment market is segmented and analyzed for demand and supply by ulcer type into a neuropathic ulcer, ischemic ulcer, and neuro-ischemic ulcer. Among these segments, the neuropathic ulcer segment is anticipated to capture the largest market size in the global diabetic foot ulcer treatment market owing to an increase in peripheral neuropathy cases among diabetics. It was observed that approximately 48% of diabetic patients experience peripheral neuropathy at some point in their lives, with prevalence ranging from 7% to 50% based on factors such as diabetes type and glycemic control. Furthermore, the number of risks associated with neuropathic ulcers, such as infection, amputation, and death, and increasing treatment options for ulcer diagnosis is projected to augment segment growth over the forecast period.
End-user
The global diabetic foot ulcer treatment market is also segmented and analyzed for demand and supply by end-user into hospitals, clinics, ambulatory surgical centers, and homecare. Amongst these four segments, the hospital segment is expected to garner a significant share. The patient suffering with diabetic ulcers should be taken to hospitals, as ulcers can lead to severe infection and it can increase the risk of amputation. Therefore, to avoid the stage of amputation, the patient should be given immediate care of the hospital for dealing with complicated ulcers. The properly trained staff of the hospital can provide intensive care and the patient can be treated with multiple services present in the hospital.
Our in-depth analysis of the global market includes the following segments:
|
By Ulcer Type |
|
|
By Product |
|
|
By End User |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Diabetic Foot Ulcer Treatment Market Regional Analysis:
North American Market Insights
The North American diabetic foot ulcer treatment market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035. The growth of the market can be attributed majorly to the ulcer type into a neuropathic ulcer, ischemic ulcer, and neuro-ischemic ulcer. Among these segments, the neuropathic ulcer segment is anticipated to capture the largest market size in the global diabetic foot ulcer treatment market owing to an increase in peripheral neuropathy cases among diabetics. It was observed that approximately 48% of diabetic patients experience peripheral neuropathy at some point in their lives, with prevalence ranging from 7% to 50% based on factors such as diabetes type and glycemic control. Furthermore, the number of risks associated with neuropathic ulcers, such as infection, amputation, and death, and increasing treatment options for ulcer diagnosis is projected to augment segment growth over the forecast period.
APAC Market Insights
The Asia Pacific diabetic foot ulcer treatment market is projected to register substantial growth till 2035. The market growth in the region is expected on the account of a rise in the number of patients suffering from diabetes. According to the World Health Organization around 77 million Indians over the age of 18 have type 2 diabetes, and over 25 million are prediabetics More than 50% of people do not know they have diabetes, which can cause serious health problems if not diagnosed timely and not provided with adequate treatment. Moreover, this number of further expected to reach around 135 million by 2045.
Diabetic Foot Ulcer Treatment Market Players:
- UPM
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Orpyx Medical Technologies Inc.
- PENTAX Medical
- Smith & Nephew plc
- Organogenesis Inc.
- SIGVARIS GROUP
- 3M
- Molnlycke Health Care AB,
- Hill-Rom Holdings, Inc.
- ConvaTec Inc.
Recent Developments
-
Orpyx Medical Technologies Inc. introduced Orpyx SI Sensory integrated with remote patient monitoring Insoles for preventing diabetic foot ulcers. It works by monitoring the temperature, pressure and movement and provide the user with real time audio-visual alarms, that enables them to take quicker decision for their health.
-
March 2022, chances of diabetes foot ulcers re-occur by half.
- Report ID: 4603
- Published Date: May 08, 2025
- Report Format: PDF, PPT
- Get detailed insights on specific segments/region
- Inquire about report customization for your industry
- Learn about our special pricing for startups
- Request a demo of the report’s key findings
- Understand the report’s forecasting methodology
- Inquire about post-purchase support and updates
- Ask About Company-Level Intelligence Additions
Have specific data needs or budget constraints?
Inquiry Before BuyingFrequently Asked Questions (FAQ)
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
Copyright @ 2025 Research Nester. All Rights Reserved.
